Publications by authors named "Gabriel Gomis"

Claim this Profile
I
Immunocytokines and cytokine neutralization for cancer immunotherapy.
Pedro Berraondo, Raquel Cuesta, Fernando Aranda, Ana Martinez-Riaño, Iñaki Eguren-Santamaria, Gabriel Gomis

Trends Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.
Alvaro Teijeira, Saray Garasa, Maria C Ochoa, Sandra Sanchez-Gregorio, Gabriel Gomis

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.
Iñaki Eguren-Santamaría, Inmaculada Rodríguez, Claudia Herrero-Martin, Eva Fernández de Piérola, Arantza Azpilikueta, Gabriel Gomis

Oncoimmunology· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The liver as a cytokine factory working on mRNA blueprints for cancer immunotherapy.
Pedro Berraondo, Gabriel Gomis, Ignacio Melero

Cancer Cell· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross-priming.
Carlos Luri-Rey, Gabriel Gomis, Javier Glez-Vaz, Almudena Manzanal, Ana Martinez Riaño

Immunol Rev· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy.
Irene Olivera, Carlos Luri-Rey, Alvaro Teijeira, Iñaki Eguren-Santamaria, Gabriel Gomis

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.
Ignacio Melero, Maria C Ochoa, Carmen Molina, Sandra Sanchez-Gregorio, Saray Garasa, Gabriel Gomis

EMBO Mol Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.
Assunta Cirella, Elixabet Bolaños, Carlos Luri-Rey, Claudia Augusta Di Trani, Irene Olivera, Gabriel Gomis

Mol Ther Nucleic Acids· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.
Javier Glez-Vaz, Arantza Azpilikueta, María C Ochoa, Irene Olivera, Gabriel Gomis

Sci Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.
Maite Alvarez, Carmen Molina, Saray Garasa, Maria C Ochoa, Maria E Rodriguez-Ruiz, Gabriel Gomis

Oncoimmunology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis